Health
US regulators bar sales of four kinds of cigarettes
Washington: US regulators on Tuesday ordered tobacco giant RJ Reynolds to stop selling and distributing four kinds of cigarettes because they are too different from previously approved cigarettes.
The four products are Camel Crush Bold, Pall Mall Deep Set Recessed Filter, Pall Mall Deep Set Recessed Filter Menthol and Vantage Tech 13 cigarettes, the US Food and Drug Administration said in
By AFP
Published September 15, 2015
Washington: US regulators on Tuesday ordered tobacco giant RJ Reynolds to stop selling and distributing four kinds of cigarettes because they are too different from previously approved cigarettes.
The four products are Camel Crush Bold, Pall Mall Deep Set Recessed Filter, Pall Mall Deep Set Recessed Filter Menthol and Vantage Tech 13 cigarettes, the US Food and Drug Administration said in a statement.
"The company´s submissions for these products did not meet requirements" that the products be "substantially equivalent" to products already on the market as of February 15, 2007, the FDA said.
"More specifically, the agency concluded the products have different characteristics than the predicate products and that the manufacturer failed to show that the new products do not raise different questions of public health when compared to them," said the FDA statement.
A key issue in the case of Camel Crush Bold appears to be the addition of a menthol capsule in the filter, which the FDA said may "affect consumer perception."
The order means that the four products can no longer be sold, distributed, imported or marketed in interstate commerce in the United States.
They were allowed on the market during a grace period established by the Family Smoking Prevention and Tobacco Control Act of 2009, which permitted companies to submit an application stating that any new products were substantially equivalent to those already for sale, which would then be reviewed by the FDA.
"These decisions were based on a rigorous, science-based review designed to protect the public from the harms caused by tobacco use," said Mitch Zeller, director of the FDA´s Center for Tobacco Products.
"The agency will continue to review product submissions and exercise its legal authority and consumer protection duty to remove products from the market when they fail to meet the public health bar set forth under law."
The four products are Camel Crush Bold, Pall Mall Deep Set Recessed Filter, Pall Mall Deep Set Recessed Filter Menthol and Vantage Tech 13 cigarettes, the US Food and Drug Administration said in a statement.
"The company´s submissions for these products did not meet requirements" that the products be "substantially equivalent" to products already on the market as of February 15, 2007, the FDA said.
"More specifically, the agency concluded the products have different characteristics than the predicate products and that the manufacturer failed to show that the new products do not raise different questions of public health when compared to them," said the FDA statement.
A key issue in the case of Camel Crush Bold appears to be the addition of a menthol capsule in the filter, which the FDA said may "affect consumer perception."
The order means that the four products can no longer be sold, distributed, imported or marketed in interstate commerce in the United States.
They were allowed on the market during a grace period established by the Family Smoking Prevention and Tobacco Control Act of 2009, which permitted companies to submit an application stating that any new products were substantially equivalent to those already for sale, which would then be reviewed by the FDA.
"These decisions were based on a rigorous, science-based review designed to protect the public from the harms caused by tobacco use," said Mitch Zeller, director of the FDA´s Center for Tobacco Products.
"The agency will continue to review product submissions and exercise its legal authority and consumer protection duty to remove products from the market when they fail to meet the public health bar set forth under law."
-
Why are South Asians at higher risk of disease? New study investigates
-
What is mental wellbeing, really? New study offers a clear answer
-
Does being married lower cancer risk? Here’s what research reveals
-
Your phone may be ageing your brain, study suggest
-
AI uncovers unreported GLP-1 drug side effects in Reddit data
-
US fertility rate drops to all-time low in 2025: What it means
-
Blue light impact on sleep smaller than believed
-
Breakthrough drugs could finally tackle deadliest ‘undruggable’ cancer mutation
-
Can aging be reversed? First human trials set to begin
-
Can 7 days change your mind? Experts break down the science of the meditative brain
-
New drug in clinical trial may finally treat hepatitis E
-
New aging brain study finds single protein behind cognitive decline and possible reversal
-
Your body’s real age may surprise you, experts say
-
High salt intake raises heart failure risk, study finds
-
How a new blood test detects active, infectious Tuberculosis: Here’s everything to know
-
Young people quit UK jobs due to health issues, study finds
-
Meningococcal disease, dangerous bacterial infection, hits decade high in Canada
-
Gene mutation may affect how schizophrenia patients see reality
Is all chocolate healthy? Here’s what the science really says
What to know before using weight-loss drugs like Ozempic